NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,820,548 | -36.8% | 116,047 | -37.3% | 0.23% | -38.7% |
| Q2 2023 | $18,691,156 | +7.1% | 185,226 | -2.3% | 0.38% | +1.9% |
| Q1 2023 | $17,447,892 | +933.4% | 189,651 | +919.0% | 0.37% | +687.2% |
| Q4 2022 | $1,688,390 | -88.8% | 18,611 | -90.6% | 0.05% | -88.1% |
| Q3 2022 | $15,089,000 | -17.0% | 198,515 | -7.7% | 0.40% | -11.0% |
| Q2 2022 | $18,178,000 | -16.1% | 215,050 | -12.9% | 0.44% | -4.3% |
| Q1 2022 | $21,676,000 | +10.3% | 247,016 | +9.9% | 0.46% | +8.2% |
| Q4 2021 | $19,652,000 | -0.8% | 224,666 | -7.3% | 0.43% | -0.2% |
| Q3 2021 | $19,811,000 | -7.9% | 242,252 | +2.7% | 0.43% | -10.0% |
| Q2 2021 | $21,517,000 | +13.0% | 235,822 | +7.8% | 0.48% | +6.0% |
| Q1 2021 | $19,038,000 | +44.5% | 218,770 | +56.7% | 0.45% | +33.0% |
| Q4 2020 | $13,174,000 | – | 139,611 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |